Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

30. März 2020 07:30 ET | Quelle: Neuronetics

Neuronetics Recognized as 2020 Top Neurology Device Provider

Company acknowledged on Top 10 List by MedTech Outlook Magazine MALVERN, Pa., March 30, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company...
16. März 2020 07:30 ET | Quelle: Neuronetics

Neuronetics® Hits Major Milestones with More Than 2.5 Million Treatments and 1,000 Installations of Its NeuroStar® Advanced Therapy System

MALVERN, Pa., March 16, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
06. März 2020 07:30 ET | Quelle: Neuronetics

FDA Grants NeuroStar® Advanced Therapy System Breakthrough Device Designation to Treat Bipolar Depression

MALVERN, Pa., March 06, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
05. März 2020 12:54 ET | Quelle: Neuronetics

Neuronetics, Inc. announces Chris Thatcher will step down as President and CEO

MALVERN, Pa., March 05, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
03. März 2020 06:00 ET | Quelle: Neuronetics

Neuronetics Reports Fourth Quarter and Full Year 2019 Financial and Operating Results

MALVERN, Pa., March 03, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
18. Februar 2020 08:00 ET | Quelle: Neuronetics

Neuronetics to Report Fourth Quarter and Fiscal Year 2019 Financial and Operating Results and Host Conference Call

MALVERN, Pa., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
21. Januar 2020 07:30 ET | Quelle: Neuronetics

Neuronetics Appoints Andrew Macan As Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary

MALVERN, Pa., Jan. 21, 2020 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
25. November 2019 07:30 ET | Quelle: Neuronetics

Neuronetics to Present at the 31st Annual Piper Jaffray Healthcare Conference

MALVERN, Pa., Nov. 25, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ:STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
05. November 2019 07:30 ET | Quelle: Neuronetics

Neuronetics Reports Third Quarter 2019 Financial and Operating Results

MALVERN, Pa., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve...
01. November 2019 07:30 ET | Quelle: Neuronetics

Neuronetics® Announces Appointment of Sheryl Conley to its Board of Directors

MALVERN, Pa., Nov. 01, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing and marketing products that improve...

Vorherige Seite